<p><i><strong>CaaMTech’s New Clinical Trial Design Solves the Emergent Functional Unblinding Problems Plaguing Psychedelic Medicine Developers</strong></i></p>

Phase 1 results demonstrate rapid absorption and response profile, highlighting Nasdepi® as an innovative alternative for emergency allergy treatment

Prognos Health, the recognized leader in lab-based precision marketing solutions, today announced the launch of its daily HCP alerts solution for select conditions.

Leapcure enhances clinical trials and affordable patient recruitment with strategic acquisition of Honeybee Trials.

Alistair Macdonald brings over 30 years of biopharmaceutical and life sciences leadership experience to Envision Pharma Group's Board of Directors

LighthouseAI Set to Impact the Regulatory Technology Industry with AI-driven Compliance

Oversubscribed round fuels growth of compliance automation solutions for pharmaceutical supply chain

New Module Automates Regulatory Updates During Corporate Transitions

Former IPM.ai executive to drive data and analytics product strategy, development, and commercialization.

Prognos Health, the largest real-world integrated data marketplace, has announced that it has raised $23 million in growth equity co-led by Marshall Wace and Safeguard Scientifics, with participation from Cigna Ventures, Hikma Ventures, Hunt Holdings, Labcorp, Maywic, Merck Global Health Innovation Fund, and Red and Blue Ventures.

FarmaKeio Outsourcing is proud to announce the release of its latest innovation, the only patented hormone pellet with triamcinolone developed in an FDA-registered 503B outsourcing facility. The pellet is set to provide a new and revolutionary solution to hormone replacement therapy for men and women.

Research is currently underway to develop Cystic Fibrosis treatments

Following Record Sales Growth and Launch of Disruptive New Product

Employees allege firing after religious exemptions to covid shot mandate were denied

Clinical Research Division to Offer Full-Service Support, Removing Barriers to Kidney Care Innovation by Providing Access to Large Patient Populations, Trial-Ready Sites, Principal Investigators

Acquisition allows Pace® to provide full-service regulatory strategy and consulting services to advance FDA submissions across a wide range of therapeutic classes.

Nation's largest reseller and service company of certified pre-owned automation and imaging lab equipment acquires Atlantic Lab Equipment of Beverly, Ma.

CaaMTech will help carry on Dr. Alexander Shulgin's legacy by developing ASRI's novel compounds

Utilizing proprietary nano-coating technology, Forge Nano is able to fundamentally improve nearly any material on earth at the atomic level.

A leading provider of sterilized sampling and testing solutions added to Filtration Group's Life Sciences business, furthering its mission of making the world safer, healthier and more productive

Tripsitter.com Becomes the Ultimate Crash Course on Psychedelics After Publishing 100 Psychedelic Monographs in 2022 Upgrade

Free, Virtual Symposium, April 25-26, 2022

Company Announces Appointment of Veteran Healthcare Communications Entrepreneur and Digital Analytics Expert, Anna Walz, to Board

Award Winner to Be Announced at Swiss Medtech Day on June 14th

Company Announces Appointment of Highly Regarded Pharmaceutical and Biotech Executive, Meg Heim, to Board

Dr. Discordia brings over 30 years of pharmaceutical industry experience to CaaMTech

Ferrer has achieved a score of 100.6 points and is among only 25% of B Corps worldwide that have exceeded 100 points.

Presentation to include clinical data from Aronora's phase 2 study of AB002, a first-in-class protein C activator enzyme that is being developed for the treatment and prevention of thrombotic and inflammatory diseases.

Scientists will assess the potential of psychedelic compounds for treating addiction

New offering surveys patients; reporting of responses to HCPs drives quicker adoption of promoted therapies

Demco Automation develops automated manufacturing systems using new robotic technologies to a growing list of industries, including life science, pharmaceuticals, biotech, medical device, defense, aerospace, electronics, commercial/industrial products, semiconductors, and consumer products.

Woven Science's El Puente foundation is pleased to release for public comment its policy paper and corporate social responsibility initiative for psychedelic pharmaceutical companies to engage with indigenous peoples using psychedelic botanicals in traditional practice. This paper explores how public policymakers in collaboration with companies can offer indigenous communities influence over product development, consumer preferences, profit sharing, and public perception.

The investment provides CaaMTech with capital to advance compounds from its library into clinical trials

Specialty Pharmacy Accreditation Indicates Pharmacies' Readiness for Value-Based Contracts

Glucosinolates industry is set to register more than 6.5% CAGR between 2021 and 2027 owing to growing consumer awareness of various health benefits of glucosinolates, such as cardiovascular, antimicrobial, antidiabetic, antitumoral, and antioxidant properties

The growing demand for aromatic solvents in the paints & coatings and automotive industries will boost the aromatic solvents market during the forecast period, says the report.

Growing awareness among consumers and the manufacturing sector regarding environmental pollution and the need for sustainable practices should drive ionic liquids demand as a green solvent with low toxicity, Says this report.

Where tactical precision, creative thinking, expert analysis, and passion provide quality outcomes.

Where tactical precision, creative thinking, expert analysis, and passion provide quality outcomes.

Black seed oil Industry is set to register around an 8% CAGR between 2021 and 2027, propelled by growing consumer inclination towards the use of herbal and natural remedies to cure health disorders.